Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Proposal in Congress
- Introduced in House
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 This bill reauthorizes through FY2029 the Sickle Cell Disease Treatment…
Read the details
What this means
- Status
- Proposal in Congress
- What happened
- Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 This bill reauthorizes through FY2029 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve prevention and treatment of sickle cell disease and complications from the disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)
- What to check next
- The bill was sent to the House Committee on Energy and Commerce for consideration.
Record details
- Bill number
- H.R. 1796
- Congress
- 119
- Introduced
- 2025-03-03
- Sponsor
- Rep. James, John [R-MI-10]
- Committees
- Energy and Commerce Committee
- Latest documented action
- Referred to the House Committee on Energy and Commerce.
Documented actions
-
Referred to the House Committee on Energy and Commerce.
-
Introduced in House
-
Introduced in House
Sources and related records
Source checked .